Hetero Drugs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is FESOTERODINE FUMARATE, with a corresponding US DMF Number 26427.
Remarkably, this DMF maintains an Active status since its submission on September 17, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 26, 2013, and payment made on November 29, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II